Correlation Between Recursion Pharmaceuticals and Xtract One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Xtract One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Xtract One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Xtract One Technologies, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Xtract One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Xtract One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Xtract One.

Diversification Opportunities for Recursion Pharmaceuticals and Xtract One

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Recursion and Xtract is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Xtract One Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xtract One Technologies and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Xtract One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xtract One Technologies has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Xtract One go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Xtract One

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 1.62 times more return on investment than Xtract One. However, Recursion Pharmaceuticals is 1.62 times more volatile than Xtract One Technologies. It trades about 0.03 of its potential returns per unit of risk. Xtract One Technologies is currently generating about 0.01 per unit of risk. If you would invest  716.00  in Recursion Pharmaceuticals on September 14, 2024 and sell it today you would lose (30.00) from holding Recursion Pharmaceuticals or give up 4.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  Xtract One Technologies

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Xtract One Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xtract One Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Recursion Pharmaceuticals and Xtract One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and Xtract One

The main advantage of trading using opposite Recursion Pharmaceuticals and Xtract One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Xtract One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xtract One will offset losses from the drop in Xtract One's long position.
The idea behind Recursion Pharmaceuticals and Xtract One Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes